Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2007

View Archived Issues

BioGeneriX and Neose extend GlycoPEG-GCSF collaboration

NovaDel raises funds to advance oral spray drug candidates

Thalidomide to be evaluated for the treatment of MIA syndrome in dialysis patients / News in Context

Grazax launched in U.K., Denmark and Norway

FDA approval for generic Atenolol Tablets

Shandong Luye acquires cancer drug CMNa

Exelixis and Genentech sign agreement for MEK inhibitor XL-518

4SC and XL TechGroup form new company to develop biofilm inhibitors

Grifols receives FDA approval for new generation of IVIG

Zydus launches Simvastatin Tablets

Perrigo receives FDA approval for Ciclopirox Topical Suspension

REG1 anticoagulant system safe in humans

VGX-1027 active against diabetes in preclinical models

PRO-132365 investigated in breast cancer trial

E75 vaccine safe and active in high-risk breast cancer

Novel monoamine reuptake inhibitors emerge from NeuroSearch R&D

Novel antibacterial agents patented

New CCR-5 receptor modulators prepared and tested at Kemia

Higher recovery rate after stroke for DP-b99-treated patients

Transdur-Bupivacaine begins phase II for postherpetic neuralgia

Phase II program under way for TD-1792 in Gram-positive cSSSI

SPA agreement for pivotal phase III study of picoplatin in SCLC

U.K. clearance for clinical study of Reolysin with docetaxel in advanced cancers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...